Effect of celery (Apium graveolens) seed extract on hypertension: A randomized, triple‐blind, placebo‐controlled, cross‐over, clinical trial

Maryam Shayani Rad,Mohsen Moohebati,Seyed Ahmad Mohajeri
DOI: https://doi.org/10.1002/ptr.7469
IF: 6.388
2022-05-29
Phytotherapy Research
Abstract:In the present work, the antihypertensive effects of celery seed extract (Apium graveolens) with active ingredients, such as 3‐n‐butylphthalide, were studied as a drug supplement in the treatment of hypertension. This study was a randomized, triple‐blind, placebo‐controlled, cross‐over clinical trial. Fifty‐two patients were divided into two groups (celery and placebo) and completed the two‐step clinical trial. Four celery seed extract capsules (totally 1.34 g per day) or 4 placebo capsules per day were administered to the patients during a 4‐week clinical trial. The blood pressure was assessed using a 24‐hr ambulatory blood pressure monitoring method. In celery group, systolic blood pressure changed from 141.2 ± 5.91 to 130.0 ± 4.38 mmHg (p .05). Furthermore, no significant side effect was reported in the celery group, compared to the placebo group (p > .05). The results were promising and indicated the therapeutic effects of celery seed extract as a supplement in the management of hypertension.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?